ENFORTUMAB
UNII U1HUE4W970

Substance Identification & Data

This profile provides standardized clinical and technical data for Enfortumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) U1HUE4W970.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1448664-46-7 and the RxNorm Concept ID (RxCUI) 2268307. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
U1HUE4W970
CAS Registry Number
1448664-46-7
RxNorm Concept ID

Detailed Substance Profile

Preferred Name
ENFORTUMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
USAN ID
BC-31
Identifier assigned by the United States Adopted Names Council.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Enfortumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ENFORTUMAB

Common Names & Synonyms

ENFORTUMAB [USAN]
IMMUNOGLOBULIN G1, ANTI-(HUMAN NECTIN-4) (HUMAN MONOCLONAL AGS-22C3 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL AGS-22C3 LIGHT CHAIN, DIMER

Technical Codes

AGS-22C3